IGC Pharma (IGC.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov14

IGC Pharma Reports Q3 Revenue Decline and Higher Net Loss

21:16

IGC Pharma released FY2026 Q2 earnings on November 14 During-Market (EST), actual revenue USD 191 K (forecast USD 383 K), actual EPS USD -0.0201 (forecast USD -0.02)

21:00

IGC Pharma released FY2026 Semi-Annual Earnings on November 14 During-Market EST, actual revenue USD 519 K, actual EPS USD -0.0394

21:00

Nov10

IGC Pharma to Release FY2026 Q2 Earnings on November 17 During-Market EST, Forecast Revenue USD 383K, EPS USD -0.02

00:08

Aug15

IGC Pharma released FY2026 Q1 earnings on August 14 (EST), actual revenue USD 328K (forecast USD 326K), actual EPS USD -0.0192 (forecast USD -0.03)

03:00

Aug5

IGC Pharma Reports Promising Preclinical Results for Alzheimer's Disease Drug Candidate

13:01

Schedules & Filings

Schedules

Filings

Nov14

Earning Release(EST)

FY2026 Q2 Earning Release (USD) Revenue 191 K, Net Income -1.821 M, EPS -0.0201

Aug14

Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 328 K, Net Income -1.599 M, EPS -0.0192

Jun27

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 330 K, Net Income -1.197 M, EPS -0.015

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change